VOYA Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96K | Buy |
|
|||||
|
2025
Q1 | $90.4K | Sell |
|
|||||
|
2024
Q4 | $149K | Sell |
|
|||||
|
2024
Q3 | $154K | Sell |
|
|||||
|
2024
Q2 | $125K | Buy |
|
|||||
|
2024
Q1 | $309K | Sell |
|
|||||
|
2023
Q4 | $985K | Sell |
|
|||||
|
2023
Q3 | $1.23M | Buy |
|
|||||
|
2023
Q2 | $1.32M | Buy |
|
|||||
|
2023
Q1 | $1.07M | Buy |
|
|||||
|
2022
Q4 | $708K | Hold |
|
|||||
|
2022
Q3 | $503K | Sell |
|
|||||
|
2022
Q2 | $391K | Buy |
|
|||||
|
2022
Q1 | $742K | Buy |
|
|||||
|
2021
Q4 | $1.58M | Buy |
|
|||||
|
2021
Q3 | $1.94M | Sell |
|
|||||
|
2021
Q2 | $2.68M | Sell |
|
|||||
|
2021
Q1 | $2.65M | Buy |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $531K | Buy |
|
|||||
|
2020
Q2 | $180K | Sell |
|
|||||
|
2020
Q1 | $224K | Buy |
|
|||||
|
2019
Q4 | $357K | Buy |
|
|||||
|
2019
Q3 | $297K | Hold |
|
|||||
|
2019
Q2 | $349K | Buy |
|
|||||
|
2019
Q1 | $405K | Hold |
|
|||||
|
2018
Q4 | $414K | Buy |
|
|||||
|
2018
Q3 | $254K | Hold |
|
|||||
|
2018
Q2 | $167K | Hold |
|
|||||
|
2018
Q1 | $96K | Hold |
|
|||||
|
2017
Q4 | $124K | Hold |
|
|||||
|
2017
Q3 | $247K | Buy |
|
|||||
|
2017
Q2 | $148K | Buy |
|
|||||
|
2017
Q1 | $183K | Hold |
|
|||||
|
2016
Q4 | $135K | Hold |
|
|||||
|
2016
Q3 | $317 | Sell |
|
|||||
|
2016
Q2 | $268K | Hold |
|
|||||
|
2016
Q1 | $323K | Hold |
|
|||||
|
2015
Q4 | $500K | Hold |
|
|||||
|
2015
Q3 | $139K | Hold |
|
|||||
|
2015
Q2 | $219K | Sell |
|
|||||
|
2015
Q1 | $256K | Sell |
|
|||||
|
2014
Q4 | $405K | Hold |
|
|||||
|
2014
Q3 | $253K | Hold |
|
|||||
|
2014
Q2 | $319K | Hold |
|
|||||
|
2014
Q1 | $276K | Buy |
|